Landscapes / Companies
Jazz Pharmaceuticals not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
5 approved
1 in Phase 2
Drugs
10
in active trials · 35 in all
Trials
21 active
144 since 2021
Drugs10
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Bispecific HER2-directed antibody |
Approved | 31 Dec 2026Phase 2 trial completes | |||
| How it works | Blocks HER2 | ||||
| Next date | 31 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Breast Cancer, Gastric Neoplasms and 16 more | ||||
| Open drug page | |||||
— |
Approved | 1 Aug 2027Phase 4 trial completes | |||
| Next date | 1 Aug 2027 · Phase 4 trial completes | ||||
| Also tested for | Lennox Gastaut Syndrome, Dravet Syndrome and 5 more | ||||
| Open drug page | |||||
— |
Approved | 23 Dec 2027Phase 3 trial completes | |||
| Next date | 23 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Narcolepsy, Idiopathic Hypersomnia | ||||
| Open drug page | |||||
Alkylating drug |
Approved | 31 Dec 2027Phase 3 trial completes | |||
| Next date | 31 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma and 4 more | ||||
| Open drug page | |||||
Protease activator |
Approved | Jun 2028Phase 3 trial completes | |||
| Next date | Jun 2028 · Phase 3 trial completes | ||||
| Also tested for | H3 K27M, Glioma | ||||
| Open drug page | |||||
— |
Phase 2 | 25 Oct 2028Phase 2 trial completes | |||
| Next date | 25 Oct 2028 · Phase 2 trial completes | ||||
| Also tested for | Central Nervous System Neoplasms, Glioblastoma and 24 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Nov 2026soonPhase 1 trial completes | |||
| Next date | 30 Nov 2026 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1 | 27 Feb 2027Phase 1 trial completes | |||
| Next date | 27 Feb 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Nov 2027Phase 1 trial completes | |||
| Next date | 30 Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Apr 2028Phase 1 trial completes | |||
| Next date | 1 Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Cancer, Metastatic Cancer and 5 more | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 25 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021